Purchase Order 75F40126P00212
Award Date 8/14/26
Potential Completion Date 12/31/26
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a purchase order to Seqmatic, LLC for next-generation sequencing RNA reagents and testing services, valued at $99,900.00, on September 4, 2025. Seqmatic is a minority-owned, Asian-Pacific American-owned small business. Work will be performed in Silver Spring, Maryland, and completion is due March 6, 2027. The order calls for bulk RNA transcriptomics analysis on primary human hepatocytes to assess drug-associated adverse liver events, including 800 RNA...
- The Food and Drug Administration awarded a $44.3K purchase order to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California, for whole exome sequencing of 95 genomic DNA samples derived from acute liver failure patients. The contract, awarded on June 21, 2023, carries a Total Small Business set-aside designation and was competitively awarded through a solicitation posted in April 2023. Work will be performed at Seqmatic's Fremont, California...
- This is a $10,520 firm fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (DEVCOM) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The contract is for bioinformatic analysis services, which are set aside for small businesses. Seqmatic is a genomics and bioinformatics services provider that has previously received prime contracts from agencies such as the USDA, NIH, CDC, FDA, NOAA, and VA for a range of...
- The U.S. government awarded Seqmatic, LLC a $67,300 firm fixed-price purchase order for high throughput RNA sequencing services. This Total Small Business set-aside contract was awarded on September 27, 2018, by a civilian agency within the Northeast Area, with an ultimate completion date of September 28, 2019. The work is to be performed in Calverton, Maryland. Seqmatic, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California, specializes in advanced...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Seqmatic, LLC for $49,700 on January 28, 2021. Seqmatic is a minority-owned, Asian-Pacific American-owned small business. The order procures single-cell RNA sequencing for induced pluripotent stem cells (iPSCs). Performance occurs in Fremont, California, with an ultimate completion date of April 28, 2021. The purchase order carries firm fixed price terms and originated from a pre-solicitation...
- This is a $49,044.00 firm fixed-price purchase order awarded to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, by the Central Program Planning Coordination and Support (VPARSCPPCS-A) division of the U.S. government's civilian agency. The contract is for RNA sequencing services and has a period of performance ending on March 31, 2025. Seqmatic provides genomics and bioinformatics services to various federal agencies, including the USDA, NIH, CDC, FDA, NOAA, and...
- The U.S. government awarded a $38,250 firm fixed-price purchase order to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, for genome sequencing services utilizing RNA sequencing (RNAseq) technology. The contract was awarded on April 28, 2023, following a competitive solicitation posted on April 19, 2023, with a five-day turnaround to submission. Work will be performed in Auburn, Alabama, with a completion date extended to December 31, 2023, via modification P00001....
- Seqmatic, LLC has been awarded a $32,485 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide single nuclei RNA sequencing sample testing services. As a minority-owned and Asian-Pacific American owned small business, Seqmatic will leverage over 10 years of experience in next generation sequencing, single cell analysis, library preparation, and bioinformatics to deliver the...
- This federal contract award was granted to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business specializing in genomics and bioinformatics services. The contract, valued at $141,475.00, was awarded by the National Institute on Drug Abuse, a civilian agency, and is set aside for small businesses. Under this firm fixed-price purchase order, Seqmatic will deliver plates sufficient to run 325 samples, some of which have been stored for ten or more years, and will perform...
- This federal contract award to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, is for the sequencing of bacterial samples for the U.S. government agency referred to as the Northeast Area. The firm fixed-price purchase order has a ceiling value of $11,490.00 and a completion date of October 5, 2018. The contract does not have a set-aside designation. Seqmatic, LLC specializes in genomics and bioinformatics services, providing a range of advanced scientific...
The Food and Drug Administration awarded a purchase order to Seqmatic, LLC for $21,960 on August 14, 2026 to perform differential expression analysis in rat brain tissue using RNA-seq. Seqmatic is a minority-owned, Asian-Pacific American-owned small business. Work is performed in Fremont, California. The order is firm fixed price with an ultimate completion date of December 31, 2026.
Generated 8/15/26, 9:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 8/13/26 |